Developing tests for precise diagnosis of age-related hearing loss
Official title: Development of a Battery of Audiological Tests for the Precision Diagnosis of Age-related Hearing Loss
Run by Institut Pasteur · NCT05312983 · Data updated 2026-11-12
This study is testing new hearing tests to better diagnose age-related hearing loss in older adults so they can get the right treatment sooner.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 700 (estimated) |
| Sponsor | Institut Pasteur Industry-sponsored |
| Locations | 2 sites (Paris and 1 other locations) |
| Status | Recruiting |
| Started | July 28, 2022 |
| Main results expected | December 31, 2027 |
| Study ends | December 31, 2030 |
| Registry record updated | March 3, 2025 |
| Trial ID | NCT05312983 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include individuals over 40 with anticipated presbycusis or those aged 18-40 with a progressive genetic hearing defect.
✕Probably not a fit
Patients with chronic exposure to loud sounds, history of ototoxic substance use, or other significant ear-related health issues may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This project aims to create a comprehensive battery of audiological tests to accurately diagnose age-related hearing loss, known as presbycusis. It involves a multi-center, non-invasive case-control study with 700 participants, including 500 individuals with anticipated presbycusis and 200 healthy controls. Participants will undergo extensive audiological, vestibular, and neurocognitive assessments over multiple visits, along with genetic analysis through blood sampling. The goal is to enhance early identification and treatment of hearing loss through tailored hearing aid adjustments.
Why it matters
Potential benefit: If successful, this study could lead to more accurate diagnoses and personalized treatment plans for patients with age-related hearing loss.
How similar studies have gone: Other studies have shown promise in developing diagnostic tools for hearing loss, but this approach is innovative in its focus on precision diagnosis through a comprehensive test battery.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: For all participants: * Be over the age of 18, * Be affiliated to a social security system, * Have a good command of the French language (oral and written). For the group of participants with anticipated presbycusis: * Over the age of 40, having a hearing aid recipient or coming for a first hearing aid recipient * Between 18 and 40, having a hearing aid recipient, coming for a first hearing aid recipient or declare a progressive genetic birth defect For healthy volunteers: \- Have no known hearing loss. Exclusion Criteria: * Report having been chronically exposed to loud sounds. * Have a history of ototoxic substances, * To have sequelae of ear infections and/or a history of ENT disease that permanently affects hearing or balance, * Have an ethnic origin for which the Pasteur Institute does not have information on the frequency of variants of the genes studied. * Have type II diabetes, * Have a neurological or psychiatric condition that interferes with comprehension or ability to move, * Be under guardianship, * Be deprived of liberty by judicial or administrative decision, or be subject to legal protection, * Not being subject to a social security system, * Taking narcotic substances, alcohol or medication that diminishes cognitive abilities.
Where it's running
-
CEntre de Recherche et d'Innovation en Audiologie Humaine
Paris, France Recruiting -
Laboratoire de correction auditive
Paris, France Not yet recruiting
Study contacts
- Principal investigator: Paul Avan, MD — Ceriah
- Study coordinator: Celine Quinsac
- Email: celine.quinsac@pasteur.fr
- Phone: +33 (0)1 76 53 50 29
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
MOPEVAC-Las vaccine in healthy adults to test safety and immune response for Lassa fever
A small study in healthy adults checks if MOPEVAC-Las is safe and can trigger an immune response, trying different dose levels.
-
Testing for viruses after a monkey bite
We will test adults who were recently bitten by a monkey or who have a history of monkey bites to see if they carry simian viruses such as STLV-1 or SFV using blood and saliva samples.
-
Speech therapy to improve lip-reading for people who use hearing aids
This will see if speech therapy for lip-reading improves visual speech recognition in adults with moderate-to-severe hearing loss who wear hearing aids.
-
How breast milk affects virus infectivity and transmission
This project will test whether components of donated breast milk change how viruses such as HTLV-1, Zika, dengue, yellow fever, and tick-borne encephalitis infect cells and could affect transmission.
-
Exploring immune responses to yellow fever vaccination
This study is testing whether yellow fever and typhoid vaccines can boost the immune system's ability to fight off other infections, and it involves collecting blood samples from participants after they get vaccinated.
-
Observing health issues faced by travelers
This study is trying to find out how often travelers get sick when visiting emerging countries and what factors might increase their risk, so we can give better advice to help keep them healthy.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.